Kyogoku unyu shoji
9073
BlueMeme
4069
Estore
4304
Visumo
303A
D. Western Therapeutics Institute
4576
(Q2)Sep 15, 2024 | (Q1)Jun 15, 2024 | (FY)Mar 15, 2024 | (Q4)Mar 15, 2024 | (Q3)Dec 15, 2023 | (Q2)Sep 15, 2023 | (Q1)Jun 15, 2023 | (FY)Mar 15, 2023 | (Q4)Mar 15, 2023 | (Q3)Dec 15, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | -4.47%1.46B | -17.39%1.29B | -16.17%5.85B | -26.39%1.38B | -5.45%1.39B | -19.42%1.53B | -10.73%1.56B | -12.26%6.98B | 8.70%1.87B | -39.41%1.47B |
Cost of revenue | -10.00%984.14M | -24.46%861.24M | -20.14%4.15B | -36.47%937.42M | -6.37%974.42M | -24.60%1.09B | -6.90%1.14B | -13.73%5.19B | 17.54%1.48B | -46.61%1.04B |
Gross profit | 9.47%474.44M | 1.90%425.7M | -4.63%1.71B | 11.45%438.28M | -3.23%418.39M | -2.54%433.38M | -19.72%417.75M | -7.70%1.79B | -15.22%393.25M | -10.30%432.36M |
Operating expense | -0.07%316.85M | -2.06%324.76M | 0.97%1.28B | 3.64%323.88M | -2.19%306.79M | 1.39%317.09M | 1.06%331.57M | 1.47%1.27B | 0.25%312.51M | -3.07%313.66M |
Operating profit | 35.51%157.59M | 17.12%100.94M | -18.18%428.49M | 41.70%114.4M | -5.98%111.61M | -11.86%116.29M | -55.18%86.18M | -24.25%523.67M | -46.91%80.74M | -25.07%118.7M |
Net non-operating interest income (expenses) | -163.42%-1.87M | 27.54%-550K | 79.60%-2.71M | 55.38%-606K | 25.59%-634K | 21.77%-708K | 92.53%-759K | -55.61%-13.27M | 21.18%-1.36M | 60.11%-852K |
Non-operating interest income | 175.00%22K | 1,700.00%18K | 92.86%27K | -15.38%11K | 187.50%7K | 0.00%8K | 0.00%1K | -44.00%14K | 18.18%13K | -900.00%-8K |
Non-operating interest expense | 163.55%1.89M | -25.26%568K | -21.82%2.73M | -23.07%617K | -24.05%641K | -21.58%716K | -18.98%760K | -59.12%3.5M | -53.75%802K | -60.51%844K |
Total other finance cost | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --9.79M | --569K | --0 |
Net investment income | -159.60%-2.44M | 188.06%7.82M | -53.23%12.74M | -47.01%2.02M | 139.82%3.91M | 2.87%4.09M | -84.76%2.71M | 74.71%27.23M | -41.15%3.82M | -71.32%1.63M |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
Income from associates and other participating interests | ||||||||||
Special income (charges) | 0 | 0 | 9,530.00%943K | 214.68%125K | 0 | 0 | 818K | 98.87%-10K | -109K | -43.10%99K |
Less:Other special charges | ---- | ---- | -9,530.00%-943K | -214.68%-125K | --0 | --0 | ---818K | -98.87%10K | --109K | ---- |
Other non-operating income (expenses) | -206.79%-6.61M | 658.74%2.17M | 1,305.89%7.87M | 42.09%790K | -7.84%611K | 441.68%6.19M | 115.88%286K | 100.64%560K | 102.55%556K | 102.83%663K |
Income before tax | 16.55%146.68M | 23.68%110.38M | -16.88%447.33M | 39.57%116.74M | -3.95%115.49M | -7.56%125.86M | -54.96%89.24M | -11.74%538.18M | -38.05%83.64M | -13.31%120.24M |
Income tax | 28.58%48.04M | 13.37%35.01M | -18.73%141.33M | 50.29%39M | -8.97%34.09M | -20.92%37.37M | -51.18%30.88M | -11.11%173.9M | -38.87%25.95M | -18.22%37.45M |
Net income | 11.46%98.64M | 29.14%75.37M | -16.00%306M | 34.74%77.74M | -1.68%81.4M | -0.45%88.49M | -56.74%58.36M | -12.04%364.28M | -37.67%57.7M | -10.89%82.79M |
Net income continuous operations | 11.46%98.64M | 29.14%75.37M | -16.00%306M | 34.74%77.74M | -1.68%81.4M | -0.45%88.49M | -56.74%58.36M | -12.04%364.28M | -37.67%57.7M | -10.89%82.79M |
Noncontrolling interests | ||||||||||
Net income attributable to the company | 11.46%98.64M | 29.14%75.37M | -16.00%306M | 34.74%77.74M | -1.68%81.4M | -0.45%88.49M | -56.74%58.36M | -12.04%364.28M | -37.67%57.7M | -10.89%82.79M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 11.46%98.64M | 29.14%75.37M | -16.00%306M | 34.74%77.74M | -1.68%81.4M | -0.45%88.49M | -56.74%58.36M | -12.04%364.28M | -37.67%57.7M | -10.89%82.79M |
Gross dividend payment | ||||||||||
Basic earnings per share | 10.02%41.93 | 27.53%32.15 | -18.81%131.64 | 36.49%33.33 | -1.24%34.99 | 0.77%38.11 | -60.90%25.21 | -20.49%162.14 | -46.68%24.42 | -22.74%35.43 |
Diluted earnings per share | 9.93%41.8927 | 27.53%32.15 | -18.81%131.64 | 35.81%33.1658 | -1.24%34.99 | 0.77%38.11 | -60.90%25.21 | -20.49%162.14 | -46.66%24.42 | -22.74%35.43 |
Dividend per share | 0.00%35 | 0 | 0.00%70 | 0.00%35 | 0 | 0.00%35 | 0 | 16.67%70 | 16.67%35 | 0 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |